Pharmacokinetic analysis of flomoxef sodium(FMOX) in cyst of jaw bone.
スポンサーリンク
概要
- 論文の詳細を見る
Flomoxef Sodium (FMOX), a new oxacephem antibiotic, was preoperatively administrated by i.v. drip infusion at a dose of 2 g for half hours in patients with cyst formation in the jaw. Then the consentration of FMOX in serum, jaw bone, cyst wall or cyst like structure in the jaws, and its content, all collected during operation, were examined. Moreover, the pharmacokinetic analysis using compartment model was performed, and following result were obtained :<BR>1. Peak levels of FMOX in serum, bone, cyst wall and its content were 122.30, 16.72 41.08, 8.48μg/ml, respectively, and the time of peak level were 0.5, 0.62, 0.61, 1.89 hours, respectively.<BR>2. The half life of FMOX (β-phase) were 1.35, 1.35, 1.35, 2.08 hours, respectively.<BR>3. The AUC values of FMOX were, 149.0, 27.4, 66.0, 52.9μg.h/ml, respectively.
- 日本歯科薬物療法学会の論文
日本歯科薬物療法学会 | 論文
- カンジダのバイオフィルム産生性に対する抗真菌薬の効果
- 当院における全身麻酔下手術中に使用された抗菌薬の15年間(1992-2006年)の推移
- 「顎骨骨髄炎に対する抗菌薬の効果判定基準」の解析結果
- 植物精油の口腔微生物に対する抗菌性およびバイオフィルム形成抑制効果の検討
- ニフェジピン歯肉増殖症患者の線維芽細胞に対する18α-グリチルレチン酸のアポトーシス誘導効果